关于我们
IN CAPITAL is an asset management firm that emphasis on healthcare industry. IN CAPITAL has an experienced professional team formed by people from healthcare and finance background. We aim to promote the development of domestic healthcare industry, provides comprehensive asset management service, and helps entrepreneurs to make strategic decisions.
We map our investments in healthcare service...
We map our investments in healthcare service...
Healthcare Service
Over the past three decades, the healthcare service around the world showed a trend of rapid growth in private hospitals, especially in China. Private healthcare institutions focus on providing higher quality healthcare service and quality clinical service for patients in areas such as diseases, primary healthcare, regional medical center, third party service center and etc.
Medical Device
With the development of various disciplines, the innovation and change of medical devices have brought new diagnosis and treatment. IN Capital pays close attention to the strong clinical demand, import substitution and innovative products that could be manufactured in large scale. Those products include but not limited in the areas such as cardiovascular, minimally invasive surgery, intervention, digestion and etc.
Biotechnology
There are some huge opportunities for the biotech industry to have structural adjustment with government policies such as “quantity purchase” and “accelerated review”. In addition, the HKEX and Sci-Tech Innovation Board cleared the way for the biotech companies to IPO with simpler criteria. IN Capital focuses on the unsatisfied clinical needs opportunities such as cancer, neurological disorders, chronic disease, orthopedics injuries, and cardiovascular disease.
In Vitro Diagnosis
In vitro diagnosis is the largest subdivision in the medical device industry globally. IN Capital focuses on the incremental market of cancer, pharmacogenomics, genetic disorders and infectious diseases.
WIT 120
The progress of information technology brings new opportunities for the whole industrial chain such as pharmaceutical R & D, distribution and device. We focus on the innovation-driven intelligent medicine especially the application and grounding scenarios of disruptive technology in medical industry, which include but not limited in artificial intelligence, big data, Internet of things, robotics and etc.
Healthcare Service
Over the past three decades, the healthcare service around the world showed a trend of rapid growth in private hospitals, especially in China. Private healthcare institutions focus on providing higher quality healthcare service and quality clinical service for patients in areas such as diseases, primary healthcare, regional medical center, third party service center and etc.
Medical Device
With the development of various disciplines, the innovation and change of medical devices have brought new diagnosis and treatment. IN Capital pays close attention to the strong clinical demand, import substitution and innovative products that could be manufactured in large scale. Those products include but not limited in the areas such as cardiovascular, minimally invasive surgery, intervention, digestion and etc.
Biotechnology
There are some huge opportunities for the biotech industry to have structural adjustment with government policies such as “quantity purchase” and “accelerated review”. In addition, the HKEX and Sci-Tech Innovation Board cleared the way for the biotech companies to IPO with simpler criteria. IN Capital focuses on the unsatisfied clinical needs opportunities such as cancer, neurological disorders, chronic disease, orthopedics injuries, and cardiovascular disease.
In Vitro Diagnosis
In vitro diagnosis is the largest subdivision in the medical device industry globally. IN Capital focuses on the incremental market of cancer, pharmacogenomics, genetic disorders and infectious diseases.
WIT 120
The progress of information technology brings new opportunities for the whole industrial chain such as pharmaceutical R & D, distribution and device. We focus on the innovation-driven intelligent medicine especially the application and grounding scenarios of disruptive technology in medical industry, which include but not limited in artificial intelligence, big data, Internet of things, robotics and etc.
